|
NOSIP expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.634800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.454000E-01 |
| Normal-vs-Stage2 |
1.905960E-01 |
| Normal-vs-Stage3 |
3.961800E-01 |
| Normal-vs-Stage4 |
7.204000E-01 |
| Stage1-vs-Stage2 |
2.454800E-01 |
| Stage1-vs-Stage3 |
5.151000E-01 |
| Stage1-vs-Stage4 |
8.976600E-01 |
| Stage2-vs-Stage3 |
5.821800E-01 |
| Stage2-vs-Stage4 |
5.498600E-01 |
| Stage3-vs-Stage4 |
8.181000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.480000E-01 |
| Normal-vs-AfricanAmerican |
9.322800E-01 |
| Normal-vs-Asian |
9.224600E-01 |
| Caucasian-vs-AfricanAmerican |
3.963200E-01 |
| Caucasian-vs-Asian |
8.033800E-01 |
| AfricanAmerican-vs-Asian |
9.219600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.764800E-01 |
| Normal-vs-Female |
9.593000E-01 |
| Male-vs-Female |
3.202400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.280600E-01 |
| Normal-vs-Extreme_Weight |
7.102200E-01 |
| Normal-vs-Obese |
7.290000E-01 |
| Normal-vs-Extreme_Obese |
6.566000E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.636000E-01 |
| Normal_Weight-vs-Obese |
9.532200E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.134750E-01 |
| Extreme_Weight-vs-Obese |
9.834800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.629970E-01 |
| Obese-vs-Extreme_Obese |
6.407800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.819600E-01 |
| Normal-vs-Age(41-60Yrs) |
4.271600E-01 |
| Normal-vs-Age(61-80Yrs) |
7.777600E-01 |
| Normal-vs-Age(81-100Yrs) |
9.946200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.497200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.540400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.140200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.154600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.886800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.849000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.298200E-01 |
| Normal-VS-Type2 PRCC |
2.828300E-02 |
| Normal-VS-KIRP CIMP |
5.104200E-02 |
| Normal-VS-Unclassified PRCC |
5.256200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
9.957800E-04 |
| Type1 PRCC-VS-KIRP CIMP |
9.688400E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.490800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.206800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.609580E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.154000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.241600E-01 |
| Normal-vs-N1 |
6.247800E-01 |
| Normal-vs-N2 |
3.093900E-02 |
| N0-vs-N1 |
8.267600E-01 |
| N0-vs-N2 |
1.466380E-01 |
| N1-vs-N2 |
2.144200E-02 |
|
|
